Antibiotic development is frequently plagued by the rapid emergence of drug resistance. However, assessing the risk of resistance development in the preclinical stage is difficult. Standard laboratory evolution approaches explore only a small fraction of the sequence space and fail to identify exceedingly rare resistance mutations and combinations thereof. Therefore,...
https://ift.tt/2K1iL23
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου